Capital Markets

Kepler Capital Markets Reiterates “Buy” Rating for AstraZeneca plc (AZN)

AstraZeneca plc (LON:AZN)‘s stock had its “buy” rating reiterated by investment analysts at Kepler Capital Markets in a research report issued on Monday, September 11th. They currently have a GBX 5,200 ($70.11) price objective on the biopharmaceutical company’s stock. Kepler Capital Markets’ price target would indicate a potential upside of 10.40% from the company’s previous close. Other research analysts have ...

Read More »

Life Storage, Inc. (LSI) Receives New Coverage from Analysts at BMO Capital Markets

BMO Capital Markets began coverage on shares of Life Storage, Inc. (NYSE:LSI) in a research note published on Monday, September 11th. The brokerage issued an underperform rating and a $73.00 price target on the real estate investment trust’s stock. A number of other research analysts have also weighed in on LSI. UBS AG reaffirmed a neutral rating and issued a ...

Read More »

Regency Centers Corporation (NYSE:REG) Coverage Initiated by Analysts at BMO Capital Markets

Research analysts at BMO Capital Markets started coverage on shares of Regency Centers Corporation (NYSE:REG) in a research note issued to investors on Monday, September 11th, MarketBeat reports. The firm set a “market perform” rating and a $65.00 price target on the real estate investment trust’s stock. BMO Capital Markets’ price target points to a potential upside of 1.64% from ...

Read More »

General Growth Properties, Inc. (GGP) Coverage Initiated at BMO Capital Markets

BMO Capital Markets began coverage on shares of General Growth Properties, Inc. (NYSE:GGP) in a report issued on Monday, September 11th. The firm issued a market perform rating and a $22.00 price objective on the real estate investment trust’s stock. Other equities analysts also recently issued reports about the stock. Zacks Investment Research raised shares of General Growth Properties from ...

Read More »

BMO Capital Markets Reiterates Buy Rating for BioMarin Pharmaceutical Inc. (BMRN)

BMO Capital Markets reiterated their buy rating on shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) in a research note issued to investors on Friday. Several other research firms also recently weighed in on BMRN. Sanford C. Bernstein initiated coverage on BioMarin Pharmaceutical in a research note on Thursday, July 27th. They issued a market perform rating and a $89.00 price target ...

Read More »

Adobe Systems’ (NASDAQ:ADBE) “Outperform” Rating Reaffirmed at BMO Capital Markets

Adobe Systems Incorporated (NASDAQ:ADBE)‘s stock had its “outperform” rating reiterated by stock analysts at BMO Capital Markets in a report released on Tuesday, September 12th. ADBE has been the subject of several other reports. Vetr cut Adobe Systems from a “hold” rating to a “sell” rating and set a $150.30 price target for the company. in a research report on ...

Read More »

Kepler Capital Markets Analysts Give Banco Bilbao Vizcaya Argentaria S.A. (BBVA) a €6.95 Price Target

Kepler Capital Markets set a €6.95 ($8.27) target price on Banco Bilbao Vizcaya Argentaria S.A. (BME:BBVA) in a report issued on Tuesday, September 12th. The firm currently has a sell rating on the stock. A number of other research firms have also recently commented on BBVA. Goldman Sachs Group, Inc. (The) set a €7.87 ($9.37) price target on Banco Bilbao ...

Read More »

Sibanye Stillwater issues $450bn bond for Stillwater acquisition

Sibanye Stillwater, a gold and platinum group metals miner, is launching a $450m convertible bond due in 2023 to complete the $2.2bn cash purchase of an American palladium and platinum mining company. Sibanye, which operates gold and platinum group metal mines in SA as well as the Stillwater mines and plants in the US, put in place a $2.65bn bridge ...

Read More »

Market Live: Nifty hovers around record closing high ahead of Fed meet

Moneycontrol News 12:24 pm Sebi approval: State-owned New India Assurance Company Ltd has received Sebi approval to float initial public offer (IPO), as per the latest update by the capital markets regulator. The country’s largest non-life insurer had filed draft prospectus with Sebi in August and received ‘observations’ from it on September 15 that are necessary for an IPO. According to ...

Read More »